This week, “all the world’s a stage,” especially for William Shakespeare, the second person to be inoculated with the Pfizer vaccine in the UK. In the U.S., an outside panel of independent experts recommended Pfizer’s vaccine approval for emergency authorization. And as indicated this morning, FDA emergency use authorization approval should come shortly.
The Best and Worst of Times
The blight of COVID-19 resulted in unfortunate milestones this week – record hospitalizations, ICU stays and most sobering, a single-day high in fatalities from the infection here in the U.S.
Two Steps Forward, One Step Back
On the back of the strongest election week returns since 1932, markets rallied sharply to begin this week as Pfizer announced 90 percent efficacy on a COVID-19 vaccine. Even more, the industries performing best were those most sensitive to economic momentum, instead of the “stay-at-home” trade that has dominated the market for the majority of the year with Amazon, Apple, Microsoft, Facebook and Google accounting for around 80 percent of the S&P 500 return.